Harris Todd — SEC insider filings
SEC reporting owner CIK 1711463. 27 insider filings on record with FilingPulse; latest filed 2026-09-17.
Transaction summary — filings shown
Covers all 27 filings on record, filed 2021-09-17 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 43 legs across 13 filings — 402,175 shares, $8,116,365 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 43.
- Largest priced transaction: sale of 78,996 shares @ $16.45 ($1,299,160) in Tyra Biosciences, Inc., filed 2024-02-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Tyra Biosciences, Inc. (TYRA) | President and CEO, Director | 27 | — | 43 legs · 402,175 sh · $8,116,365 | 43 |
Insider filings — Harris Todd
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-17 | 4 | Tyra Biosciences, Inc. (TYRA) | Grant/award (A): 864 @ $9.13 | EDGAR |
| 2026-05-07 | 4 | Tyra Biosciences, Inc. (TYRA) | Grant/award (A): 79,000 @ $0 · Grant/award (A): 265,000 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | Tyra Biosciences, Inc. (TYRA) | Grant/award (A): 1,463 @ $9.13 | EDGAR |
| 2025-08-07 | 4 | Tyra Biosciences, Inc. (TYRA) | Grant/award (A): 570,000 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | Tyra Biosciences, Inc. (TYRA) | Grant/award (A): 1,241 @ $9.78 | EDGAR |
| 2024-10-22 | 4 | Tyra Biosciences, Inc. (TYRA) | Sale (S): 43,636 @ $27.01 · Sale (S): 5,896 @ $27.32 · Sale (S): 13,188 @ $28.16 | EDGAR |
| 2024-10-17 | 4 | Tyra Biosciences, Inc. (TYRA) | Sale (S): 10,035 @ $24.31 · Sale (S): 4,900 @ $25.22 · Sale (S): 24,475 @ $26.23 · Sale (S): 3,922 @ $26.98 · Sale (S): 15,194 @ $25.84 · Sale (S): 200 @ $26.37 | EDGAR |
| 2024-10-02 | 4 | Tyra Biosciences, Inc. (TYRA) | Sale (S): 500 @ $24 | EDGAR |
| 2024-09-25 | 4 | Tyra Biosciences, Inc. (TYRA) | Sale (S): 10,092 @ $24.13 · Sale (S): 1,055 @ $24.02 · Sale (S): 600 @ $24.01 | EDGAR |
| 2024-09-20 | 4 | Tyra Biosciences, Inc. (TYRA) | Sale (S): 3,500 @ $24 · Sale (S): 5,671 @ $24.30 · Sale (S): 27 @ $25.10 · Sale (S): 7,109 @ $24.19 | EDGAR |
| 2024-09-17 | 4 | Tyra Biosciences, Inc. (TYRA) | Grant/award (A): 1,350 @ $6.58 | EDGAR |
| 2024-08-16 | 4 | Tyra Biosciences, Inc. (TYRA) | Grant/award (A): 390,000 (derivative) @ $0 | EDGAR |
| 2024-03-19 | 4 | Tyra Biosciences, Inc. (TYRA) | Grant/award (A): 1,880 @ $6.58 | EDGAR |
| 2024-02-06 | 4 | Tyra Biosciences, Inc. (TYRA) | Sale (S): 78,996 @ $16.45 · Sale (S): 7,187 @ $17.04 · Sale (S): 13,817 @ $16.97 | EDGAR |
| 2023-09-19 | 4 | Tyra Biosciences, Inc. (TYRA) | Grant/award (A): 1,421 @ $6.58 | EDGAR |
| 2023-08-01 | 4 | Tyra Biosciences, Inc. (TYRA) | Grant/award (A): 330,000 (derivative) @ $0 | EDGAR |
| 2023-06-26 | 4 | Tyra Biosciences, Inc. (TYRA) | Sale (S): 2,978 @ $16.98 · Sale (S): 500 @ $17.39 · Sale (S): 14,231 @ $16.78 · Sale (S): 6,481 @ $17.51 | EDGAR |
| 2023-06-21 | 4 | Tyra Biosciences, Inc. (TYRA) | Sale (S): 3,316 @ $16.49 · Sale (S): 50,838 @ $17.06 · Sale (S): 600 @ $18.50 · Sale (S): 1,300 @ $16.53 · Sale (S): 4,629 @ $16.12 · Sale (S): 14,027 @ $17.71 · +1 more | EDGAR |
| 2023-06-15 | 4 | Tyra Biosciences, Inc. (TYRA) | Option exercise (M): 7,927 @ $2.25 · Sale (S): 7,927 @ $16.00 · Option exercise (M): 12,773 @ $2.25 · Sale (S): 12,773 @ $16.13 · Option exercise (M): 7,927 (derivative) @ $0 · Option exercise (M): 12,773 (derivative) @ $0 | EDGAR |
| 2023-04-05 | 4 | Tyra Biosciences, Inc. (TYRA) | Option exercise (M): 2,000 @ $2.25 · Sale (S): 2,000 @ $16.13 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2023-03-31 | 4 | Tyra Biosciences, Inc. (TYRA) | Option exercise (M): 1,420 @ $2.25 · Sale (S): 1,420 @ $16.18 · Option exercise (M): 2,407 @ $2.25 · Sale (S): 2,407 @ $16.02 · Option exercise (M): 500 @ $2.25 · Sale (S): 500 @ $16.05 · +3 more | EDGAR |
| 2023-03-28 | 4 | Tyra Biosciences, Inc. (TYRA) | Option exercise (M): 170 @ $2.25 · Sale (S): 170 @ $16 · Option exercise (M): 2,963 @ $2.25 · Sale (S): 2,963 @ $16 · Option exercise (M): 2,779 @ $2.25 · Sale (S): 2,779 @ $16 · +3 more | EDGAR |
| 2023-03-23 | 4 | Tyra Biosciences, Inc. (TYRA) | Option exercise (M): 12,393 @ $2.25 · Sale (S): 12,393 @ $16 · Option exercise (M): 4,043 @ $2.25 · Sale (S): 4,043 @ $16 · Option exercise (M): 2,800 @ $2.25 · Sale (S): 2,800 @ $16 · +3 more | EDGAR |
| 2023-03-17 | 4 | Tyra Biosciences, Inc. (TYRA) | Grant/award (A): 1,808 @ $6.58 | EDGAR |
| 2022-09-08 | 4 | Tyra Biosciences, Inc. (TYRA) | Grant/award (A): 3,125 @ $8.53 · Grant/award (A): 270,000 (derivative) @ $0 | EDGAR |
| 2021-11-04 | 4 | Tyra Biosciences, Inc. (TYRA) | Grant/award (A): 215,038 (derivative) @ $0 · Grant/award (A): 25,884 (derivative) @ $0 · Grant/award (A): 25,884 (derivative) @ $0 | EDGAR |
| 2021-09-17 | 4 | Tyra Biosciences, Inc. (TYRA) | Conversion (C): 34,007 · Conversion (C): 13,093 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-09-13 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1711463 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs